Glycaemic control in people with diabetes following acute myocardial infarction

Despite significant changes to the management of AMI over the last 20 years, with the introduction of early revascularization as standard of care, people sustaining an AMI with diabetes persist as a subgroup at high risk of complications including death, heart failure, stroke, nonfatal myocardial infraction and death, as inpatients [1 –2], within 30 days [1], at 6-12 months [1], and in the longer term [3–5]. Concerningly, in people with a background of poly-vascular disease, or in people experiencing an MI complicated by clinical signs of heart failure or left ventricular dysfunction, who have a high baseline risk for complic ations following AMI [6], diabetes independently confers additional risk of complications and mortality [6–7].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Tags: Review Source Type: research